Wednesday, January 13, 2016

Pain-killer Diclofenac discovered to have anti-cancer properties

Diclofenac is a pain-killer commonly used to treat migraines, fever, rheumatoid arthritis, and gout.

Recently, Repurposing Drugs in Oncology (ReDO) project discovered that Diclofenac has anti-cancer properties. Experts from United States and Belgium who form part of the ReDO team believe that Diclofenac can assist cancer patients undergoing treatments according to UPI reports.

Researchers are likewise hoping that Diclofenac would limit metastasis that eventually tends to kind people.

Diclofenac is sold over-the-counter under the names Voltaren, Zipsor, Solaraze and Cambia.

Currently, ReDO team is researching on the non-steroidal anti-inflammatory drug’s (NSAID) effects on cancer in four clinical trials.

If the trials will prove successful, cancer patients will save a lot considering that Diclofenac is cheap and a generic one.

Digg Google Bookmarks reddit Mixx StumbleUpon Technorati Yahoo! Buzz DesignFloat Delicious BlinkList Furl

0 comments: on "Pain-killer Diclofenac discovered to have anti-cancer properties "

Post a Comment